IGFAX
Price
$13.88
Change
+$0.05 (+0.36%)
Updated
Jan 17 closing price
Net Assets
286.65M
RWIAX
Price
$64.07
Change
+$0.46 (+0.72%)
Updated
Jan 17 closing price
Net Assets
126.7B
Ad is loading...

IGFAX vs RWIAX

Header iconIGFAX vs RWIAX Comparison
Open Charts IGFAX vs RWIAXBanner chart's image
VY® Morgan Stanley Global Franchise A
Price$13.88
Change+$0.05 (+0.36%)
VolumeN/A
Net Assets286.65M
American Funds Capital World Gr&Inc R1
Price$64.07
Change+$0.46 (+0.72%)
VolumeN/A
Net Assets126.7B
IGFAX vs RWIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IGFAX vs. RWIAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGFAX is a Buy and RWIAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIAX has more cash in the bank: 127B vs. IGFAX (287M). RWIAX pays higher dividends than IGFAX: RWIAX (1.04) vs IGFAX (0.20). IGFAX was incepted earlier than RWIAX: IGFAX (18 years) vs RWIAX (23 years). IGFAX has a lower initial minimum investment than RWIAX: IGFAX (0) vs RWIAX (250). RWIAX annual gain was more profitable for investors over the last year : 10.05 vs. IGFAX (-2.05). RWIAX return over 5 years is better than : 24.84 vs. IGFAX (-15.42).
IGFAXRWIAXIGFAX / RWIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years23 years-
Gain YTD1.3142.02265%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets287M127B0%
Annual Yield % from dividends0.201.0419%
Returns for 1 year-2.0510.05-20%
Returns for 3 years-18.496.93-267%
Returns for 5 years-15.4224.84-62%
Returns for 10 years-10.6344.36-24%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXA6.410.29
+4.74%
Nexa Resources SA
IRTC108.331.34
+1.25%
iRhythm Technologies
ES57.87-0.25
-0.43%
Eversource Energy
FULC3.96-0.02
-0.50%
Fulcrum Therapeutics
MTR6.75-0.09
-1.32%
Mesa Royalty Trust